Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-051212
Filing Date
2025-05-21
Accepted
2025-05-21 06:01:12
Documents
3
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2515775d1_6k.htm 6-K 10413
2 EXHIBIT 99.1 tm2515775d1_ex99-1.htm EX-99.1 16624
3 GRAPHIC tm2515775d1_ex99-1img001.jpg GRAPHIC 3911
  Complete submission text file 0001104659-25-051212.txt   33625
Mailing Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 858-246-6240
BELITE BIO, INC (Filer) CIK: 0001889109 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41359 | Film No.: 25970796
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)